Global
Contact Us
DKSH has been recognized as a Great Place to Work® in 16 key markets, surpassing the number of certified markets in the previous year. DKSH has also been named one of the “Fortune 100 Best Companies to Work For™ Southeast Asia 2025”. These achievements reaffirm DKSH’s work environment and underscore its ongoing commitment to fostering a great corporate culture.
DKSH has announced Natale Capri as the sole Head of the Business Unit Performance Materials, building on his more than ten years of experience as Business Unit Co-Head. Thomas Sul, the former Co-Head, will transition into retirement.
DKSH has achieved another milestone in its sustainability efforts, as the Science Based Targets initiative (SBTi) has officially validated its near-term and net zero targets. This approval reflects DKSH’s commitment to its climate ambitions and reinforces its goal of achieving net-zero emissions by 2050.
DKSH has signed an agreement to acquire Biomedic Science Material Joint Stock Company (“Biomedic”), a leading distributor of equipment and reagents used in the biotechnology and diagnostic market in Vietnam. With this transaction, DKSH Technology further extends its scientific solutions business in line with the Business Unit’s strategy to solidify its position as a leading scientific solutions provider in Asia and Beyond.
DKSH announced today that it has signed an agreement to acquire Invita (NZ) Limited in New Zealand and Invita Australia Pty Limited in Australia (“Invita”). With this transaction, DKSH Performance Materials enhances its capabilities in the attractive food and beverage market, particularly in the dairy and nutritional segments, and strengthens its position as a leading life science and industrial specialties distributor in Asia Pacific.
DKSH Business Unit Healthcare Launches a three-part whitepaper series to help healthcare and life science companies explore industry trends and current market pressures to re-think commercial go-to market approaches in the Asia Pacific region. The whitepaper series demonstrates how strategic Commercial Outsourcing partnerships are evolving to deliver sustainable growth, resource agility, and improved patient access – successfully harnessing the region’s growing USD 10 billion healthcare outsourcing opportunity.
DKSH Holding Ltd. (“DKSH”) has, through its 100%-owned subsidiary DKSH Resources (Malaysia) Sdn Bhd (“DKSH Resources”), today submitted an offer to fully take over its Malaysian subsidiary DKSH Holdings (Malaysia) Berhad (“DHMB”) by taking over the remaining outstanding 25.7% of shares currently held by minority shareholders. As part of DKSH’s ongoing efforts to simplify company structures, DKSH subsequently aims to delist DHMB from the Malaysian stock exchange.
DKSH has entered a partnership with Parhelia Bioscience, pioneers of spatial biology automation to be their exclusive distributor in Australia and New Zealand.
DKSH appoints Patrik Grande as new Head Business Unit Healthcare and new member of the Executive Committee. He follows Bijay Singh who will retire after eleven years at DKSH.
DKSH Business Unit Performance Materials has been certified with the EcoVadis Gold Rating for its strong sustainability performance. The recognition highlights exceptional results in labor and human rights, as well as advanced ratings in environment, ethics, and sustainable procurement, demonstrating that sustainability is firmly embedded in the Business Unit’s operations.
DKSH celebrates its 160th anniversary, tracing its origins back to Japan in 1865. As the oldest foreign company with an uninterrupted presence in Japan, DKSH has contributed to the region’s economic development for over a century. This rich history, combined with the strong Swiss heritage, has shaped DKSH into the company it is today – a trusted partner for businesses seeking to grow in Asia and beyond.
DKSH and Chiesi have successfully secured approval to add a rare ophthalmic disease medication to the national reimbursement list in the key market in Asia, enabling earlier patient access to important eye disease treatment.
DKSH has been recognized as an “Industry Leader” for its sustainability performance in the 2025 ISS ESG Corporate Rating as the results have increased to B- (from C+). This improvement reflects DKSH’s continued commitment to sustainability, especially highlighting its climate strategy and participation in the Science Based Targets Initiative.
Core EBIT increased by 5.1% (at CER1) to CHF 169.3 million Core EBIT margin expanded by 10 basis points to 3.1% Net sales grew by 2.1% (at CER) to CHF 5.5 billion Five M&A transactions announced in H1 2025 Strong Free Cash Flow of CHF 121.6 million (cash conversion 117.5%) Confirmed outlook for 2025
Agrion Crop Solutions emerges from DKSH Agrisolutions, keeping up its leading position as a manufacturer of premium crop protection products. This new brand identity reflects the company’s evolution and reinforces its commitment to innovation, precision, and customer success in the agricultural and turf industry across Australia and New Zealand.
DKSH Business Unit Technology has expanded its distribution agreement with Ametek Brookfield, a globally recognized leader in material characterization, in New Zealand. By distributing Ametek Brookfield’s viscosity measurement solutions, DKSH further strengthens its material sciences and characterization portfolio.
DKSH has been recognized as a Great Place to Work® in multiple key markets. This certification affirms the excellent work environment at DKSH and reflects the ongoing commitment to supporting and empowering its employees. DKSH aims to attain this certification across further markets as part of its continued focus on maintaining a high-performing corporate culture.
DKSH enters into a partnership with Klimate for carbon dioxide (CO2) removal solutions to further its mission of achieving net-zero operations. In line with the ongoing CO2 emissions reduction initiatives, DKSH will be procuring high-quality, verifiable CO2 removal credits from Klimate.
DKSH’s sustainability efforts have been recognized by EcoVadis with the Gold Medal, placing DKSH among the top 5% of rated companies globally. The improved score highlights DKSH’s continued dedication to sustainability and its proactive approach in advancing responsible business practices.
Shareholders approved all motions with a clear majority Reelection of the current Board members seeking another term as well as the Chairman of the Board of Directors, and appointment of a new Board member Proposal of dividend increase of 4.4% to CHF 2.35 per share accepted
DKSH has received Global ISO certifications for environmental practices (ISO 14001) as well as occupational health and safety (ISO 45001) across multiple markets. This achievement reinforces DKSH’s commitment to sustainability and safety in its supply chains, which are continuously improved. DKSH aims to extend these ISO certifications to other key markets in the future.
Net sales reached CHF 11.1 billion (4.0% at CER1) Core EBIT increased to CHF 343.1 (8.4% at CER1) Core EBIT margin expanded by >10 basis points to 3.1% (4th consecutive year) Free Cash Flow of CHF 256.5 million (cash conversion of 113.6%) Dividend proposal of CHF 2.35 per share (+4.4%)2 Mid-term roadmap confirmed
At today’s Capital Markets Day in London, DKSH outlines its mid-term roadmap based on the strategic priorities of growth, margin expansion, and accelerated M&A. The company presents updated Business Unit strategies and at the same time drives sustainability by committing to set a science based target. DKSH reconfirms its outlook for 2024.
DKSH Healthcare and Euris have launched “ConnectPlus”, a complete Customer Relationship Management (CRM) and Multi-Channel Engagement (MCE) platform set to transform healthcare distribution across APAC. This data-driven, agile solution enhances efficiency by providing a comprehensive view of healthcare professionals and optimizing omnichannel engagement strategies. From January 2025, ConnectPlus will strengthen DKSH Healthcare’s commitment to commercial excellence by boosting engagement with clients, customers, and patients across the healthcare ecosystem in Thailand.
DKSH has expanded its exclusive distribution agreement with Cosucra, a leading producer of natural and healthy food ingredients, in Australia and New Zealand. By distributing Cosucra’s dietary fibers and plant-based proteins, DKSH will boost business opportunities for the partnership in the market.
Continued value creation in H1 2024 Core EBIT increased by 8.2% (at CER1) to CHF 163.6 million Core EBIT margin expanded by 10 basis points to 3.0% Net sales grew by 3.3% (at CER) to CHF 5.4 billion Consumer Goods Core EBIT margin reached mid-term target of 2.5% Strong Free Cash Flow of CHF 160.8 million (cash conversion 136.0%) Confirmed outlook for 2024 Capital Markets Day on November 18 in London
DKSH has extended its distribution agreement with KRONOS, a leading global producer and marketer of titanium dioxide (TiO2) pigments, in Australia, New Zealand, Japan, and the Philippines. Through its distribution network and service offering, DKSH will boost business opportunities for the partnership in the four key Asian Pacific markets.
Shareholders approved all motions with a clear majority All current Board members reelected Proposal of dividend increase of 4.7% to CHF 2.25 per share accepted
Net sales reached CHF 11.1 billion (5.3% at CER1) Core EBIT grew to CHF 329.9 million (12.6% at CER1) Core EBIT margin expanded by >15 basis points to 3.0% Free Cash Flow of CHF 282.3 million (cash conversion at 137.0%) Dividend proposal of CHF 2.25 per share (+4.7%)2 Capital Markets Day planned in H2 2024
DKSH’s commitment to sustainability has been recognized with the internationally renowned EcoVadis Gold Medal for the second time. With its improved score, DKSH now ranks among the top 4% of all companies rated by EcoVadis. This recognition acknowledges its ongoing commitment to sustainability and its efforts to further pursue responsible business practices.
DKSH has signed an agreement to acquire Bio-Strategy Limited (“Bio-Strategy”), the largest independent distributor of scientific instruments in Australia and New Zealand. With this acquisition, DKSH grows its Scientific Instrumentation business in line with Business Unit Technology’s strategy to build resilience and deliver profitable growth.
DKSH has converted its existing CHF 150 million revolving credit facility loan into a sustainability-linked revolving credit facility. This is the second sustainable finance instrument DKSH has entered into within this year, further strengthening its commitment to increase gender diversity in its senior leadership team positions, and become climate neutral (Scope 1+2) by 2030.
DKSH has announced the acquisition of New Zealand’s leading independent beauty product distributor CS&Co. today. With the acquisition, DKSH Business Unit Consumer Goods strengthens its capabilities in the growing beauty sector in New Zealand.
DKSH has signed a distribution agreement with Lactobio, a leading developer of microbiome solutions for personal care applications, in key markets across Asia Pacific and Europe.
DKSH has further fortified its strategic partnership with Biolin Scientific, a globally recognized pioneer in surface science instrumentation, across nine key markets in the APAC region.
Net sales increased to CHF 5.6 billion (7.2% at CER1) Core EBIT grew double digit to CHF 162.6 million (15.5% at CER) Core EBIT margin expanded by 15 basis points to 2.9% Free Cash Flow of CHF 179.0 million and strong cash conversion of 168.2% Confirmed outlook for 2023
DKSH has signed an exclusive distribution agreement with bitop, a leading manufacturer of cosmetics ingredients, in Australia, New Zealand, Malaysia, and Singapore.
DKSH has converted its existing CHF 315 million bank loan into a sustainability-linked loan by tying the interest terms to its ambitious sustainability targets. These targets are consistent with DKSH's overall sustainability strategy to increase gender diversity in its senior leadership team and become climate neutral (Scope 1+2) by 2030.
DKSH has published its 2022 Sustainability Report, outlining its revised sustainability strategy and the progress made on environmental, social, and governance-related topics. Alongside, DKSH also publishes its first Task Force on Climate-Related Financial Disclosures (TCFD) Report.
Shareholders approved all motions with a clear majority All current Board members re-elected Gabriel Baertschi elected as new member of the Board of Directors Proposal of dividend increase of 4.9% to CHF 2.15 per share accepted
DKSH has been appointed as official distributor for Hettich’s scientific instruments in Australia and New Zealand. This partnership is in line with the strategic focus of DKSH Business Unit Technology to solidify its position as a leading integrated solutions provider for the scientific instrumentation market.
EBIT growth of 12.2% to CHF 319.2 million All Business Units improved performance Free Cash Flow of CHF 209.5 million (Cash Conversion 100.6%) Closing of ten acquisitions Dividend proposal of CHF 2.15 per share (+4.9%)3
DKSH has been awarded distribution rights with Dow Consumer Solutions’ product range of silicones and silanes for composites applications in Australia, New Zealand, Thailand, Singapore, Vietnam, Indonesia, and the Philippines.
DKSH has signed an agreement to acquire two ear care brands from Noru Pharma for Australia, New Zealand, and selected markets in Asia. The acquisition is in line with DKSH's strategy to grow in higher value-added segments and services and it expands its Healthcare Own Brands business to 14 markets in Asia Pacific.
DKSH’s commitment to Sustainability has been recognized with the internationally renowned EcoVadis Gold Rating. With its score DKSH ranks among the top 5% of the companies rated by EcoVadis.
Aspiring to champion global product and food waste reduction efforts, the Fast Moving Consumer Goods (FMCG) services provider DKSH has embarked on a partnership with The Global FoodBanking Network to scale its endeavors to recover and distribute surplus product across Asia Pacific.
DKSH has started a strategic relationship with Corning Life Sciences, a trusted supplier to the healthcare and pharmaceutical industries, to distribute its products in Australia, Indonesia, Malaysia, New Zealand, the Philippines, Singapore, Thailand, and Vietnam.
EBIT increased by 16.6% to CHF 153.3 million (19.9% at CER¹) driven by all four Business Units EBIT margin expanded by 30 basis points to 2.7% Net sales grew by 2.0% to CHF 5,596.2 million (3.7% at CER¹) RONOC increased by 170 basis points to 20.4% Disciplined strategy and M&A execution (six acquisitions signed) Confirmed outlook for 2022
Today, DKSH has published its 2021 Sustainability Report, showing good progress on its environmental, social, and governance targets. DKSH reduced its total Scope 1 and 2 emissions by 40% in 2021, ahead of the 35% target until 2025. With this, DKSH has announced a new target to reduce 65% of its own greenhouse gas emissions by 2025. Also, DKSH now employs 29% females in senior leadership positions, up from 27% in 2020.
DKSH has started a new partnership with Wuxi NEST Biotechnology, a leading manufacturer of plastic laboratory products, to distribute its products in Australia, Indonesia, New Zealand, the Philippines, Singapore, Thailand, and Vietnam.
DKSH has entered an agreement with Stilla Technologies in Asia. This partnership is in line with the strategic focus of DKSH Business Unit Technology to solidify its position as a leading integrated solutions provider for the scientific Instrumentation market.
DKSH has joined the United Nations Global Compact initiative, the largest corporate responsibility initiative in the world, further strengthening its commitment to sustainability.
Shareholders approve all motions All Board members re-elected Dividend increase to CHF 2.05 per share approved
DKSH has started a new partnership with ICSPI, a leading supplier of benchtop Atomic Force Microscope (AFM) instruments in Asia Pacific.
DKSH appoints Sam Oh, Chief Information Officer, as new member of the Executive Committee. At the same time, Daniel Culverhouse, currently Head Supply Chain Management, has decided to leave the company for personal reasons.
DKSH has started a new partnership with IOI Oleo, a leading supplier of oleochemical specialties, for Australia, New Zealand, the Philippines, Taiwan, South Korea, and Vietnam.
Net sales increase of 5.4%1 EBIT growth of 10.5% to CHF 284.6 million Profit after tax 39.6% higher than 20203 Free Cash Flow grows by 24.5% to CHF 261.6 million Consistent with progressive dividend policy, dividend 5.1% higher at CHF 2.05 per share4
DKSH has entered a strategic agreement with FlowGen, a technology leader of light weight, high performance wind turbines, to expand their business in the APAC region.
DKSH has signed a strategic agreement with Curiox Biosystems to promote their cell washing technology in key Asian markets. This partnership is in line with the strategic focus of DKSH Business Unit Technology to solidify its position as a leading integrated solutions provider for the Scientific Instrumentation market.
DKSH's Business Unit Performance Materials, a leading distributor of specialty chemicals and ingredients, has released a major upgrade to Discover, its innovative digital customer portal.
PSPhere Lite+ is DKSH's innovative patient engagement platform and part of the company's digital transformation journey.
DKSH Australia and New Zealand has partnered with Vink Chemicals, a leading producer of technical biocides for industrial applications.
DKSH returns to growth with net sales reaching CHF 5.5 billion (+5.3%)¹Consistent strategy implementation results in 20.7% EBIT increase to CHF 131.5 million¹DKSH completes four value-accretive acquisitionsFree Cash Flow doubles compared to H1 2020
DKSH has signed a distribution agreement with Honeywell, the American multinational technology conglomerate, to provide its range of high-quality polyethylene waxes in Australia, China, New Zealand, Japan and the Philippines.
DKSH expands Business Unit Healthcare by acquiring Hahn Healthcare, an Australian medical engagement company. The transaction supports DKSH's strategy to offer wide market coverage across Asia Pacific and its focus on value-added services and sales force outsourcing.
DKSH's Business Unit Performance Materials serves business partners in the food and beverage industry with formulation and blending expertise from its dedicated blending facility in the Philippines. Starting today, DKSH operates the facility with renewable energy, thereby substantially reducing its carbon emissions.
Despite COVID-19, DKSH reports key figures broadly stable on last year's level – at CER1Second consecutive year of EBIT growth in Fast Moving Consumer GoodsStrong Free Cash Flow of CHF 210.2 million (+34.1%)Assuming an easing of the impact of COVID-19, higher EBIT expected in 2021
DKSH further strengthens its regional footprint in Asia Pacific by partnering with Australian company Care Pharmaceuticals in New Zealand.
DKSH has entered an exclusive distribution agreement with Elementis for Australia and New Zealand
By integrating specialty chemicals distributor Axieo, DKSH has gained broader market coverage and customer reach in the Asia Pacific region and now assumes a leading role in the Australian and New Zealand markets.
DKSH has entered into partnership with Eastman, a global specialty materials company, to provide their specialties for the personal care industry to the Asia Pacific region.
DKSH and LabVantage Solutions have signed an agreement covering its Laboratory Information Management System (LIMS) for twelve countries in the APAC region.
DKSH has been appointed by Zydus Wellness International DMCC to distribute the leading international brand Complan in New Zealand.
DKSH, a leading Market Expansion Services provider and Binder, the world's leader in simulation chambers and incubators have extended their strategic partnership for DKSH to be the exclusive agent across key markets in Asia.
The partnership between DKSH and International SOS has helped implement DKSH's Total Quarantine Solution which provides health and hygiene measures to safeguard the health and safety of supply chain staff in distribution centers across Asia.
DKSH has entered an exclusive distribution agreement with Keyland Polymer UV Materials Spain SLU. The company is a leading American and European producer of polymers for UV curable powder coatings.
DKSH and Ubiquitome have signed an exclusive agreement in South East Asia, Australia and New Zealand to introduce Liberty16, a handheld, battery-powered, real-time polymerase chain reaction (PCR) device that can fast test and relay sample data via an iPhone app within 40 minutes.
DKSH has entered into an exclusive agreement with PZ Cussons to promote their leading international brands in New Zealand.
DKSH has entered an exclusive distribution agreement with ddchem, the leading, Italy-based producer of hardeners for epoxy systems and hot melt polyamides. DKSH will provide ddchem's products in Spain, Portugal and APAC.
DKSH has reached agreement with General Mills to distribute all its products across New Zealand. This will allow DKSH to invest in market expansion services to deliver growth.
By completing the acquisition of specialty chemicals distributor Axieo, DKSH continues to drive market consolidation and assumes a leading role in the Australian and New Zealand markets.
By closing the acquisition of the largest field marketing provider Crossmark in Australia and New Zealand, DKSH once again acquires a target in a growing business segment and adds value for its clients and customers.
DKSH grew net sales and EBITGood progress with restructuring yielded higher result for Business Unit Consumer GoodsAcquisition strategy pursued with four value-creating transactionsProposal to increase ordinary dividend to CHF 1.90 per share (+2.7%)Confident for outlook 2020
The agreement to acquire specialty chemicals distributor Axieo is a continuation of DKSH's acquisition strategy, allowing the company to expand its coverage in Asia Pacific and to become a market leader in Australia and New Zealand.
DKSH and Harvard Bioscience have signed a distribution agreement covering its wide range of scientific instruments used to advance life science research in Asia Pacific.
DKSH, the leading Market Expansion Services provider with a focus on Asia Pacific, is selected to drive growth ofLa Zuppa in New Zealand.
DKSH and Industrial Physics, the world's leading manufacturer of packaging and material testing equipment, have signed a distribution agreement covering its wide range of brand portfolios for Asia Pacific.'
DKSH has been rewarded for its commitment to Sustainability with the internationally recognized EcoVadis silver rating. With an overall score of 50 points, DKSH ranks among the top 14% of companies in the industry. As a Swiss company with a legacy of over 150 years in Asia, Sustainability is an integral part of DKSH's business model.
DKSH, the leading Market Expansion Services provider with a focus on Asia Pacific, has been appointed by Peters Ice Cream, an Australian company, to drive growth of its iconic OREO® Ice Cream products in New Zealand.
DKSH and Novo Nordisk Pharmatech A/S, a leading global supplier of high-quality ingredients for the biopharmaceutical and pharmaceutical industries, have partnered to provide high-quality cGMP quaternary ammonium compounds in eleven markets across Asia Pacific.
DKSH, the leading Market Expansion Services provider with a focus on Asia Pacific, and PepsiCo Australia & New Zealand, a market leader and supplier of drinks and snack foods, have entered a partnership for New Zealand.
DKSH ensures continuity in leadership by appointing Daniel Culverhouse as Head Supply Chain Management, effective October 1, 2018.
DKSH, the leading Market Expansion Services provider with a focus on Asia Pacific, has been appointed by SC Johnson, a global household products company, to drive growth of its products in New Zealand.
DKSH, the leading Market Expansion Services provider with a focus on Asia, and Bruker AXS, a leading provider of Analytical X-ray Solutions, have signed a multi-product line distribution agreement in five countries in Asia Pacific.
DKSH, the leading Market Expansion Services provider with a focus on Asia Pacific, has been appointed by 3M, a global science company, to drive growth of its products in New Zealand.
Approval of the Financial Statements and Group Consolidated Financial Statements for the financial year 2017Shareholders authorized the distribution of an ordinary dividend of CHF 1.65 per shareAll members of the Board of Directors and Senior Executive Team were dischargedApproval of the compensation of the Board of Directors and Senior Executive TeamElection of Prof. Dr. Annette G. Köhler and Eunice Zehnder-Lai as new members of the Board of DirectorsShareholders voted in favor of all Board members who stood for re-election, re-elected the Chairman and elected four members to the Nomination and Compensation CommitteeRe-election of Statutory Auditors and Independent Proxy
DKSH, a leading Market Expansion Services provider, will showcase an exciting portfolio of ingredients for pharmaceutical formulation and synthesis at CPhI Worldwide 2017.
DKSH, the leading Market Expansion Services provider with a focus on Asia Pacific, and Jordans Dorset Ryvita, a market leader and supplier of breakfast cereals and biscuits, have signed an exclusive agreement for New Zealand.
DKSH, the leading Market Expansion Services provider with a focus on Asia Pacific, and Agilent Technologies, a market leader and supplier of chemical analysis equipment and consumables, have signed an exclusive distribution agreement for New Zealand.
The continued positive growth dynamics in the Asian markets offer promising development opportunities for companies. With an average annual growth rate of 6.5% over the next five years, the future outlook of Market Expansion Services in Asia remains prosperous as shown by the new study from Roland Berger.
DKSH Holding Ltd. (SIX: DKSH) reports its full-year results 2016 on Monday, February 6, 2017
DKSH, the leading Market Expansion Services provider with a focus on Asia Pacific, has taken out the Distribution and Logistics Award at the 2016 Westpac Manawatu Business Awards in New Zealand.
Net sales grow by 2.3% to CHF 5.1 billionDKSH gains further market sharesOperating profit (EBIT) of CHF 135.7 million impacted by one-time contract adjustments in Business Unit Healthcare. Excluding adjustments, EBIT exceeds last year's levelIncreasing demand for performance materials for the industrial development and expansion leads to substantially higher profitability in this Business UnitMeasures in the luxury goods business start to take effectPositive trend intact: DKSH continues to expect net sales and earnings growth for full-year
DKSH, the leading Market Expansion Services provider with a focus on Asia Pacific, has signed an agreement with McCormick Foods to market and distribute a selected product range in New Zealand.
DKSH, the leading Market Expansion Services provider with a focus on Asia Pacific, supports the growth of its clients in the country with the opening of a new head office and distribution center for New Zealand in Palmerston North.
DKSH, the leading Market Expansion Services provider with a focus on Asia, and C-Therm, a Canadian provider of sensor solutions for research and development, manufacturing and quality control applications, have signed an exclusive distribution agreement for C-Therm's Thermal Conductivity Analyzer and Dilatometer product line for Australia and New Zealand.
DKSH, the leading Market Expansion Services provider with a focus on Asia, and Leifeld, a world leader in the development and manufacturing of machine tools for chipless metal forming based in Germany, have signed an exclusive distribution agreement covering ten countries in Asia Pacific.
DKSH, the leading Market Expansion Services provider with a focus on Asia, was awarded the “2014 Evonik Strategic Distributor of the Year” award in the category “Excellence in Distribution” by Evonik Channel Management.
DKSH, the leading Market Expansion Services provider with a focus on Asia Pacific, has renewed its agreement with Red Bull, the world's most popular energy drink, continuing a very successful partnership.
DKSH's Chief Financial Officer Bernhard Schmitt was acclaimed at a ceremonial award in Hong Kong for his outstanding achievements as Head of the Finance function of DKSH, the leading Market Expansion Service provider with a focus on Asia.
DKSH, the leading Market Expansion Services provider with a focus on Asia and Novasina, a Swiss precision instrument specialist, extend their partnership to Korea, Australia and New Zealand following outstanding sales in Japan and China.
DKSH, the leading Market Expansion Services provider with a focus on Asia, operates in an attractive market with a projected growth of 7.4% per year up to 2019, as confirmed by the most recent market study conducted by Roland Berger Strategy Consultants.
Roland Berger Strategy Consultants and DKSH today published the latest Global Market Expansion Services (MES) report, which highlights digitization and its importance for the Market Expansion Services industry. Based on data from leading research institutes, the report offers valuable insights to both Market Expansion Services providers and their clients and customers, helping decision-makers gain a better understanding of the opportunities and challenges of digital market expansion.
The Board of Directors of DKSH will propose at the next ordinary Annual General Meeting held on April 15, 2014, the election of David Kamenetzky to the Board of Directors. David Kamenetzky is currently a member of Mars, Incorporated's global management team, responsible for Corporate Affairs and Strategic Initiatives.
DKSH, the leading Market Expansion Services provider with a focus on Asia, operates in a highly attractive market with a projected growth of 7.8% per year up to 2018, as confirmed by the most recent market study conducted by Roland Berger Strategy Consultants.
Reach out to our Group Media Relations team for any inquiries.
Head, Investor and Media Relations & Sustainability, and Head, Finance Healthcare Own Brands
Manager, Group Media Relations
Contact us to discover new opportunities.